Your browser doesn't support javascript.
loading
Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients.
Li, Meng; Xu, Tianjiao; Zhang, Zhao; Xue, Xiaochang; Zhang, Cun; Qin, Xin; Li, Weina; Hao, Qiang; Zhang, Wei; Zhang, Yingqi.
  • Li M; State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Fourth Military Medical University, Xi'an, China.
Cancer Sci ; 103(2): 288-95, 2012 Feb.
Article en En | MEDLINE | ID: mdl-22085427
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Factor de Necrosis Tumoral alfa / Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2012 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Factor de Necrosis Tumoral alfa / Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2012 Tipo del documento: Article